…for affiliates, at the end of the day, they’re a non-profit, they just don’t want to—they want to break even. And if they can do a little better than break even, and do so in a way that seems reasonable, they’re happy to do that. Really their bottom line is, they want to break even. Every penny they save is a just pennies they give to another patient. To provide a service the patient wouldn’t get.”
It’s just business, after all, and in case there was any doubt, a flyer produced by an actual biotech company unequivocally emphasises profit as a motive in its pitch to “clinics”:
“StemExpress promotes global biomedical research while also providing a financial benefit to your clinic. By partnering with StemExpress, not only are you offering a way for your clients to participate in the unique opportunity to facilitate life-saving research, but you will also be contributing to the fiscal growth of your own clinic. The stem cell rich blood and raw materials that are usually discarded during procedures can, instead, be expedited through StemExpress to research laboratories with complete professionalism and source anonymity.”
Check out their great prices on foetal liver cells!
Biotech is big business, and StemExpress boasts of being a multi-million dollar company with a global market. On the one hand, none of this should come as a surprise, and there are so many “wins” to this story that it’s hard to imagine any legal action coming out of it. Count the “wins”: big business, profit-sharing, “life-saving research”, turning “waste material” into valuable research material, and giving women ambivalent about ending the life of their unborn child the opportunity to “donate” to on-going research. As the Planned Parenthood executive put it:
“Every patient experiences a whole wide range of emotions about the experience in general, and so you don’t know where they’re coming at from there. But I think every one of them is happy to know that there’s a possibility for them to do ‘this extra bit of good,’ in what they do.”
Welcome to a new era of human sacrifice
There have been debates in the pro-life movement about using graphic imagery – that is, images of aborted foetuses – to try to bring home the reality of abortion to an ambivalent and largely ignorant population. Stories like this achieve a similar end, shocking many who have never really put two-and-two together when it comes to the act of abortion as opposed to abstract arguments about rights and humanity. It’s one thing to support “a woman’s right to choose” and quite another to resist blanching at a Planned Parenthood executive’s casual references to sought-after body-parts: lungs, livers (“always as many intact livers as possible”), and lower extremities (legs and feet) as well.
This candid business conversation belies the still-influential claims that abortion is merely the removal of a non-descript “blob of tissue” or “clump of cells”. Revealing the particulars of the business and research interest in aborted foetuses will shock people who never considered organ harvesting and abortion in the same context.
In science the term “sacrifice” is commonly used to describe the killing of an animal for research purposes; cooperative relationships between abortion providers, researchers, and middle-men suggests we have already entered a phase of de facto human sacrifice for research purposes.
Welcome to a society that devours its own children; where, through various avenues, the destruction and manipulation of human life, and commodification and objectification of human remains is increasingly entrenched in our economic fabric, and where commercial and research operations have quietly normalised the use of aborted human remains “for the benefit of all”.
Zac Alstin is associate editor of MercatorNet. He also blogs at zacalstin.com.
This article first appeared at MercatorNet. It is reprinted here with kind permission.